Tariffs on Medicines From Europe Stand to Cost Drugmakers Billions

Health
By Rebecca Robbins from NYT Health https://ift.tt/y0DNV8t
via IFTTT Drugs (Pharmaceuticals), Customs (Tariff), Prices (Fares, Fees and Rates), International Trade and World Market, Factories and Manufacturing, Supply Chain, United States Politics and Government Many pharmaceutical products made in Europe will face a 15 percent tariff, pinching manufacturers and potentially leading to higher drug prices.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda